racemetirosine and n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide

racemetirosine has been researched along with n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brown, AK; Cropley, VL; Fujita, M; Innis, RB; Lerner, A; Nathan, PJ; Pike, VW; Ryu, YH; Sangare, JL; Sprague, KE	1

Trials

1 trial(s) available for racemetirosine and n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide

Article	Year
Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans. Synapse (New York, N.Y.), 2008, Volume: 62, Issue:6 Topics: Administration, Oral; Adult; alpha-Methyltyrosine; Amphetamine; Analysis of Variance; Benzamides; Binding, Competitive; Brain; Brain Mapping; Dopamine; Dopamine Uptake Inhibitors; Enzyme Inhibitors; Female; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Positron-Emission Tomography; Pyrrolidines; Reproducibility of Results	2008

Article

Year

Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans.

Synapse (New York, N.Y.), 2008, Volume: 62, Issue:6

Topics: Administration, Oral; Adult; alpha-Methyltyrosine; Amphetamine; Analysis of Variance; Benzamides; Binding, Competitive; Brain; Brain Mapping; Dopamine; Dopamine Uptake Inhibitors; Enzyme Inhibitors; Female; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Positron-Emission Tomography; Pyrrolidines; Reproducibility of Results

2008